Public Sector Pension Investment Board Has $28.92 Million Stock Holdings in CVS Health Corporation $CVS

Public Sector Pension Investment Board trimmed its position in shares of CVS Health Corporation (NYSE:CVS) by 4.9% during the 3rd quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 383,590 shares of the pharmacy operator’s stock after selling 19,562 shares during the period. Public Sector Pension Investment Board’s holdings in CVS Health were worth $28,919,000 at the end of the most recent quarter.

Several other institutional investors also recently modified their holdings of CVS. Avion Wealth raised its stake in shares of CVS Health by 99.0% in the second quarter. Avion Wealth now owns 380 shares of the pharmacy operator’s stock valued at $26,000 after purchasing an additional 189 shares in the last quarter. Harbor Capital Advisors Inc. raised its stake in shares of CVS Health by 72.1% in the 3rd quarter. Harbor Capital Advisors Inc. now owns 339 shares of the pharmacy operator’s stock valued at $26,000 after buying an additional 142 shares in the last quarter. Corundum Trust Company INC bought a new position in shares of CVS Health during the 3rd quarter worth about $29,000. Harbor Asset Planning Inc. acquired a new stake in shares of CVS Health during the 2nd quarter valued at about $30,000. Finally, Front Row Advisors LLC increased its stake in CVS Health by 436.5% in the second quarter. Front Row Advisors LLC now owns 456 shares of the pharmacy operator’s stock valued at $31,000 after acquiring an additional 371 shares during the period. Institutional investors and hedge funds own 80.66% of the company’s stock.

Analyst Ratings Changes

A number of brokerages have commented on CVS. Piper Sandler restated an “overweight” rating and set a $101.00 price target (up previously from $99.00) on shares of CVS Health in a research note on Wednesday, December 10th. Weiss Ratings reaffirmed a “hold (c-)” rating on shares of CVS Health in a research note on Monday, December 29th. JPMorgan Chase & Co. upped their price target on CVS Health from $93.00 to $101.00 and gave the company an “overweight” rating in a research report on Wednesday, December 17th. Barclays lifted their price objective on CVS Health from $87.00 to $93.00 and gave the company an “overweight” rating in a report on Wednesday, December 10th. Finally, UBS Group reaffirmed an “outperform” rating on shares of CVS Health in a report on Wednesday, December 10th. Nineteen analysts have rated the stock with a Buy rating and four have assigned a Hold rating to the company’s stock. According to data from MarketBeat.com, CVS Health presently has an average rating of “Moderate Buy” and a consensus price target of $94.91.

CVS Health Stock Up 0.7%

Shares of NYSE:CVS opened at $78.45 on Friday. The company has a quick ratio of 0.63, a current ratio of 0.84 and a debt-to-equity ratio of 0.80. The firm has a market cap of $99.80 billion, a P/E ratio of 56.85, a P/E/G ratio of 0.81 and a beta of 0.50. CVS Health Corporation has a 12 month low of $58.35 and a 12 month high of $85.15. The company’s 50-day moving average price is $78.64 and its two-hundred day moving average price is $76.13.

CVS Health (NYSE:CVS) last announced its earnings results on Tuesday, February 10th. The pharmacy operator reported $1.09 earnings per share for the quarter, topping analysts’ consensus estimates of $1.00 by $0.09. CVS Health had a net margin of 0.44% and a return on equity of 11.31%. The company had revenue of $105.69 billion during the quarter, compared to the consensus estimate of $103.67 billion. During the same period in the previous year, the firm posted $1.19 earnings per share. The company’s revenue was up 8.2% on a year-over-year basis. CVS Health has set its FY 2026 guidance at 5.940-6.140 EPS. As a group, research analysts forecast that CVS Health Corporation will post 5.89 EPS for the current fiscal year.

CVS Health Dividend Announcement

The company also recently disclosed a quarterly dividend, which was paid on Monday, February 2nd. Shareholders of record on Thursday, January 22nd were given a $0.665 dividend. This represents a $2.66 dividend on an annualized basis and a yield of 3.4%. The ex-dividend date was Thursday, January 22nd. CVS Health’s dividend payout ratio (DPR) is presently 192.75%.

About CVS Health

CVS Health Corporation is a diversified healthcare company that operates a large network of retail pharmacies, pharmacy benefit management services and health care solutions. Headquartered in Woonsocket, Rhode Island, the company traces its roots to the early 1960s and has grown into an integrated provider of prescription drugs, over‑the‑counter products, clinical services and health insurance offerings. Its operating model combines retail pharmacy locations and in‑store clinics with broader pharmacy and health plan capabilities.

Key business activities include CVS Pharmacy retail operations, MinuteClinic walk‑in medical clinics and HealthHUB locations that offer expanded clinical services.